MA

Mayur Anand

Active Director Director DIN 10243435
DIN 10243435 First appointment Jul 2023 Primary industry Paper
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value •••• Premium profile

About Mayur Anand

Data last updated:

Mayur Anand is a Director at Ashlite Pharmaceuticals Private Limited (since 2023). The company operates in Paper. Ashlite Pharmaceuticals Private Limited reported revenue of ₹7.6 Lakh (FY 2025).

DIN 10243435
Primary Designation Director
Industry Paper
First Appointment 18 Jul 2023
Oldest Company Age 3 yrs
Largest company Ashlite Pharmaceuticals Private Limited · ₹7.6 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Jul 20232023₹7.6 Lakh (FY 2025)Active

Board colleagues of Mayur Anand

NameDINCompanyDesignation
Ekta Soorma10243436Ashlite Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ashlite Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Mayur Anand

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mayur Anand

Mayur Anand currently holds 1 directorship: Ashlite Pharmaceuticals Private Limited (Director, since 18 Jul 2023, revenue ₹7.6 Lakh (FY 2025)).

Mayur Anand was first appointed on 18 Jul 2023 as Director at Ashlite Pharmaceuticals Private Limited.

The current boards of Mayur Anand's companies include Ekta Soorma (Ashlite Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available